Clinical Trial Update: Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season [Phase 1]

View source ↗

Summary

This Phase 1 study assessed the tolerability and safety of intranasal AZD8848 in healthy male volunteers and in male patients with seasonal allergic rhinitis, c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• AZD8848

Snippet

Sponsor: AstraZeneca | Conditions: Healthy, Allergic Rhinitis | Phase 1 | Status: COMPLETED